Impact of Pneumococcal Conjugate Vaccine on Vaccine Serotype-Specific Pneumonia

被引：1
|
作者：
Klugman, Keith P. [1 ]
Rodgers, Gail L. [1 ]
机构：
[1] Bill & Melinda Gates Fdn, Seattle, WA USA
来源：
CLINICAL INFECTIOUS DISEASES | 2021年 / 73卷 / 07期
关键词：
Streptococcus pneumoniae; pneumococcus; serotype; pneumonia; pneumococcal conjugate vaccine; STANDARDIZED INTERPRETATION; CHILDREN YOUNGER; DOUBLE-BLIND; AGE; PREVENTION; EFFICACY;
D O I：
10.1093/cid/ciaa1867
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E1434 / E1435
页数：2
相关论文
共 50 条
  • [11] Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan
    Nisar, Muhammad Imran
    Jehan, Fyezah
    Shahid, Shahira
    Ahmed, Sheraz
    Shakoor, Sadia
    Kabir, Furqan
    Hotwani, Aneeta
    Muneer, Sahrish
    Khalid, Farah
    Muhammad, Sajid
    Althouse, Benjamin M.
    Hu, Hao
    Whitney, Cynthia G.
    Ali, Asad
    Zaidi, Anita K. M.
    Omer, Saad B.
    Iqbal, Najeeha
    PLOS ONE, 2022, 17 (01):
  • [12] Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study
    Andrews, Nick J.
    Waight, Pauline A.
    Burbidge, Polly
    Pearce, Emma
    Roalfe, Lucy
    Zancolli, Marta
    Slack, Mary
    Ladhani, Shamez N.
    Miller, Elizabeth
    Goldblatt, David
    LANCET INFECTIOUS DISEASES, 2014, 14 (09): : 839 - 846
  • [13] Pneumococcal Conjugate Vaccine Impact on Serotype 3: A Review of Surveillance Data
    Sings, Heather L.
    Gessner, Bradford D.
    Wasserman, Matt D.
    Jodar, Luis
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 521 - 539
  • [14] Pneumococcal Conjugate Vaccine Impact on Serotype 3: A Review of Surveillance Data
    Heather L. Sings
    Bradford D. Gessner
    Matt D. Wasserman
    Luis Jodar
    Infectious Diseases and Therapy, 2021, 10 : 521 - 539
  • [15] Pneumococcal pneumonia in the era of heptavalent pneumococcal conjugate vaccine
    Payeras, Antoni
    Villoslada, Aroa
    Garau, Margarita
    Borras, Maria
    Pareja, Antonio
    Beingolea, David
    Garcia-Gasalla, Mercedes
    del Carmen Gallegos, M.
    Jose Alonso-Villaverde, Carlos
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (04): : 250 - 256
  • [16] Serotype 19A Bacteremic Pneumococcal Pneumonia After 4 Doses of 13-Valent Conjugate Vaccine: A Review of Pneumococcal Conjugate Vaccine Effectiveness
    Tam, Pui-Ying Iroh
    Hanisch, Benjamin R.
    Forward, Brennan
    CLINICAL PEDIATRICS, 2015, 54 (06) : 591 - 593
  • [17] A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands
    Gessner, Bradford D.
    Jiang, Qin
    Van Werkhoven, Cornelis H.
    Sings, Heather L.
    Webber, Chris
    Scott, Daniel
    Gruber, William C.
    Grobbee, Diederick E.
    Bonten, Marc J. M.
    Jodar, Luis
    VACCINE, 2019, 37 (30) : 4147 - 4154
  • [18] Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: A systematic review and pooled analysis
    McLaughlin, John M.
    Jiang, Qin
    Gessner, Bradford D.
    Swerdlow, David L.
    Sings, Heather L.
    Isturiz, Raul E.
    Jodar, Luis
    VACCINE, 2019, 37 (43) : 6310 - 6316
  • [19] The Divergent Effect of Different Infant Vaccination Schedules of the 13-Valent Pneumococcal Conjugate Vaccine on Serotype-Specific Immunological Memory
    Tzovara, Irene
    Papadatou, Ioanna
    Tzanoudaki, Marianna
    Piperi, Christina
    Kanaka-Gantenbein, Christina
    Spoulou, Vana
    VACCINES, 2024, 12 (09)
  • [20] Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine
    Clutterbuck, Elizabeth A.
    Oh, Sarah
    Hamaluba, Mainga
    Westcar, Sharon
    Beverley, Peter C. L.
    Pollard, Andrew J.
    CLINICAL AND VACCINE IMMUNOLOGY, 2008, 15 (02) : 182 - 193
12345